Kidney Transplantation, Cytomegalovirus Infections Clinical Trials in Taipei

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study